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Abstract
Objective: As part of the value-based healthcare programme in our hospital, a set of 
patient-reported outcome measures was developed together with patients and im-
plemented in the dedicated Turner Syndrome (TS) outpatient clinic. This study aims 
to investigate different aspects of health-related quality of life (HR-QoL) and psycho-
social functioning in women with TS in order to establish new possible targets for 
therapy.
Design/Participants: A comprehensive set of questionnaires (EQ-5D, PSS-10, CIS-20, 
Ferti-QoL, FSFI) was developed and used to capture different aspects of HR-QoL and 
psychosocial functioning in a large cohort of adult women with Turner syndrome. All 
consecutive women, ≥18 years, who visited the outpatient clinic of our tertiary centre 
were eligible for inclusion.
Results: Of the eligible 201 women who were invited to participate, 177 women (age 
34 ± 12 years, mean ± SD) completed at least one of the validated questionnaires 
(88%). Women with TS reported a lower health-related quality of life (EQ-5D: 0.857 
vs 0.892, P = .003), perceived more stress (PSS-10:14.7 vs 13.3; P = .012) and expe-
rienced increased fatigue (CIS-20: P < .001) compared to the general Dutch popu-
lation. A relationship between noncardiac comorbidities (eg diabetes, orthopaedic 
complaints) and HR-QoL was found (R = .508).
Conclusions: We showed that TS women suffer from impaired HR-QoL, more per-
ceived stress and increased fatigue compared to healthy controls. A relationship be-
tween noncardiac comorbidities and HR-QoL was found. Especially perceived stress 
and increased fatigue can be considered targets for improvement of HR-QoL in TS 
women.
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1  | INTRODUC TION
Turner syndrome (TS), first described by Henry Turner in 1938, is 
caused by a partial or complete monosomy of the X-chromosome 
and occurs in 1 per 2500 live born females.1,2 Classic characteris-
tics of TS include: short stature, webbing of the neck, oestrogen 
deficiency and decreased fertility.3-5 Moreover, significant morbid-
ity in these patients is caused by the cardiovascular abnormalities 
of heart and thoracic vessels, which affect an estimated 50% of 
women with TS.6 Of these congenital defects the bicuspid aortic 
valve (BAV: 15%-30%), coarctation of the aorta (CoA 12%-17%) and 
partial anomalous pulmonary venous return (PAPVR: 18%-25%) are 
most prevalent.2,6-8 Additionally diabetes, obesity and hypertension 
are often seen in these women, adding to their cardiovascular risk.9 
Although cardiovascular and other physical morbidities of women 
with TS have already been described in detail, literature is still incon-
clusive or contradictory on the impact of TS on HR-QoL.10 In addi-
tion to the physical factors, HR-QoL in these women is also affected 
by the mild neuropsychological deficits these patients may encoun-
ter, such as the relative weakness in visual-spatial, executive and so-
cial cognitive domains.11-13 Additionally, other factors such as lower 
socioeconomic status or impaired ability to work may affect QoL. 
Finally, fertility issues may also have impact on QoL in TS women. 
Since the phenotype is so multi-dimensional and heterogeneous, 
traditional psychometric tools, such as the SF-36, cannot com-
pletely capture the broad range of psychosocial problems in these 
patients.14 Moreover, the importance of psychometrically sound 
disease-specific tools has been stressed in other chronic illnesses, 
where more generic tools often fail to capture loss of quality of life 
on disease-specific domains.15 In this study, we describe the devel-
opment and first results of a set of clinician and patient-reported 
outcome set in Turner syndrome as part of the value-based health-
care programmes in our hospital.16 We aim to provide a comprehen-
sive evaluation of HR-QoL and different domains of psychosocial 
functioning in women with TS in order to identify individual and 
disease-specific targets for effective improvement of their HR-QoL.
2  | METHODS
2.1 | Development of the outcome set
For the development of such a set, out organization works according 
to a so called blueprint which is adapted to the specific situation of a 
disease team. This way of working is described in detail elsewhere.16 
In brief, a disease team is formed consisting of the most important 
disciplines involved in the treatment, in this case the departments 
of internal medicine, gynaecology and cardiology. A representation 
of patients is invite to participate in this process. In our situation, 
we had a 24-year-old patient and the mother of a patient being also 
member of the national patient organization; they are volunteers for 
the Turner patients federation and have been in contact with and 
of support to many Turner women. With this group and technically 
supervised by a value-based healthcare expert, the team discussed 
in four sessions the following items: current care path, possible out-
come measures from literature and complemented with topics from 
the patients that really matter to them. Consensus based this long 
list of outcome topics was decreased to a more discrete based on 
frequency and impact. Finally, the outcome topics were translated 
into validated outcome measures and built into our data capture tool 
in order to measure them electronically. Before every outpatient 
clinic visit, patients receive an email with a web link to the questions, 
so they were able to answer them at home before the visit. During 
the visit, the result was discussed with them. Our tertiary care cen-
tre has developed a 5-year VBHC-strategy to transform the institute 
into a true value innovator. An integrated, multidisciplinary Turner 
syndrome-care unit was already in place within our institute. The 
Turner team is composed of a cardiologist, endocrinologist, gynae-
cologist, physiotherapist, psychologist and ENT specialist, and other 
specialists are consulted upon indication.
For women with Turner syndrome, navigating the complex 
healthcare pathway involving many specialties can be daunting. 
Therefore, this pathway was redesigned analogous to the breast 
cancer care pathway described earlier (Ref 16). A critical step within 
VBHC is defining an outcomes set, and this was done with the de-
scribed multidisciplinary team. After both a literature survey and 
from experience, all participants worked on a long list of outcome 
domains and ranked based on prevalence, impact for the patient and 
relevance for quality of care. For sake of feasibility, the final list was 
discussed and selected using a modified Delphi method, see figure. 
The PROMS selected are described below under ‘instruments’ and in 
more detail in Appendix S1.
As described earlier, PROMS in the VBHC-pathways in our insti-
tution are captured using an in-house developed open source elec-
tronical data collection tool, which allows the construction of data 
collection-forms and automatic distribution of PROMs (Ref. 16). Emails 
are sent to the patients in order to activate the distribution of PROMs. 
After the right treatment, pathway is selected by the physician, and all 
the following PROMs will be sent automatically by the tool at the right 
time-point. The tool was linked to the EHR enabling the review of the 
collected data for individual patients at the (outpatient) clinic. The se-
cure platform is build-up by two software programs, LimeSurvey17 and 
GemsTracker.18 The development team simultaneously developed a 
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user-friendly interface to display the collected data. Longitudinal PRO 
data and data from the caregivers are collected in these pathways.
2.2 | Setting and study design
All patients in our centre of expertise are seen according to a new 
value-based healthcare clinical pathway which includes annual 
visits to the dedicated Turner outpatient clinic.5,19 Adult women 
with Turner syndrome who visited the outpatient clinic between 
December 2015 and October 2018 were prospectively included. 
Cardiovascular examination was performed including electro-
cardiography (ECG) and transthoracic echocardiogram (TTE) and 
advanced cardiac imaging (CT or CMR). Karyotype was taken 
from the clinical genetics report. The study complied with the 
Declaration of Helsinki and was approved by the medical ethical 
committee of the Erasmus Medical Centre. Written informed con-
sent was waived.
2.3 | Instruments
As a part of a hospital wide value-based healthcare programme 
patients were asked to complete 12 questionnaires: 5 standard-
ized questionnaires: the EuroQol-5D (EQ-5D), Hospital Anxiety 
and Depression Scale (HADS), Checklist Individual Strength 
(CIS-20), Perceived Stress Scale (PSS-10), Fertility Quality of 
Life (Ferti-QoL), 4 questionnaires on sexual functioning (sexual 
activity question, brief sexual symptom checklist for women 
(BSSC-W), female sexual functioning index (FSFI) and the female 
sexual distress scale-revised (FSFD-R)) and 3 questionnaires on 
body image and the perceived burden questionnaires.20-22 The 
questionnaires have been described in more detail in supplemen-
tary methods. The sexuality questionnaires were offered to the 
women with TS aged 20 and 45 years because sexuality starts 
later in women with TS 23-26 and end earlier because of hormonal 
changes.
2.4 | Statistics
Continuous variables were presented as mean ± standard deviation 
(SD) or as median with an interquartile range. Categorical variables 
were presented as frequencies and percentages. We examined dis-
tributions by visually assessing histograms of the data by calculat-
ing Z-values of skewness and kurtosis, and by tested for normality 
using the Shapiro-Wilk test. For comparison of normally distrib-
uted continuous variables between two groups, the Student's t 
test was used. Univariate linear regression analysis was performed. 
Subsequently, multivariate linear regression analysis was per-
formed to identify patient characteristics that were significantly as-
sociated with different measures of HR-QoL or other psychosocial 
outcomes. In case of collinearity, we entered the variable with the 
strongest correlation with the outcome into the multivariate linear 
regression analysis. As previously described the tri-modal distri-
bution of the EQ-5D outcome measure hampers ordinary least-
squares (OLS) regression, three-part regression methods seem to 
have better prediction power than OLS with EQ-5D data, although 
OLS seems quite robust.27 Therefore, we conducted separate linear 
regression for the .5-.99 range as an additional ‘sensitivity analysis’. 
The statistical tests were two sided, and a P-value below .05 was 
considered significant. The IBM spss® statistics 21.0 software was 
used to analyse the data.
3  | RESULTS
The questionnaires were offered to all 201 women with TS who vis-
ited our outpatient clinic between December 2015 and September 
2018, of which 177 women completed at least one of the ques-
tionnaires (response rate: 88%) and were included in this study. 
Baseline characteristics of the 177 women are presented in Table 1. 
The mean time to complete the questionnaires was 15 minutes. All 
women seen in our outpatient clinic between the age of 18 and 52 
use HRT.
3.1 | Demographics and morbidity
Many women indicated living with a partner (Table 2; n = 50, 28%). 
Of the women living with parents or family (n = 51), 15 (29%) were 
TA B L E  1   Baseline characteristics
Baseline characteristics
Women with TS
Median [IQR]
Age, y 33 [18]
Height, cm 157 [11]
Weight, kg 64 [19]
Systolic BP, mm Hg 125 [21]
Diastolic BP, mm Hg 76 [17]
Body surface area, m2 1.65 [0.22]
Body mass index, kg/m2 25.4 [6.4]
Sinus rhythm, n = 167 167 (100)
Heart rate, bpm 75 (15)
Karyotype 171 (97)
Monosomy X 93 (52.5)
Mosaic 25 (14)
Isochromosomes 25 (14)
Deletions 6 (3.4)
Polyploidy 9 (5.1)
Ring chromosomes 5 (2.8)
Y material 8 (4.5)
Note: Continuous data are presented as mean ± SD. Categorical data are 
presented as n (%).
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older than 25 years of age. In total, 29 women (16%) raised a total of 
30 children. The highest level of educational attainment was known 
in 123 (69%) participants; most of who had finished intermediate 
vocational education in 51 (29%). Women were often employed, 
either fulltime (n = 23, 13%) or part-time (n = 26, 20%). Of the 90 
participants, less than half indicated to practice sports regularly, on 
average 3 hours (median, IQR 3 hours) per week. Noticeably, all but 
1 participant practiced individual sports. Data on morbidity is pre-
sented in Table 3. Most frequently encountered problems included: 
ear and/or hearing problems (n = 57; 32%) and cardiovascular dis-
ease (n = 56; 32%). In the 56 women with cardiac disease, several 
different structural heart defects were identified, of which a bicus-
pid aortic valve (BAV) was the most frequent (19%). Aortic dilata-
tion was found in 10 patients (6%), and 1 patient had suffered from 
dissection (0.6%).
3.2 | Primary outcome
3.2.1 | EQ-5D
The EQ-5D was completed by nearly all patients (n = 175, 99%). 
Women with TS scored lower compared to the general Dutch pop-
ulation (0.857 vs 0.892; P = .003) as shown in Figure 1.28 Women 
with TS scored significantly higher on the ‘problems with daily ac-
tivity’ (P < .001) and the ‘fear and anxiety’ (P < .001) compared to 
healthy controls (Figure S1). Finally, the EQ-5D included a subjec-
tive ‘health score’ (EQ-VAS; Figure S2), where the women with TS 
(n = 176) scored significantly lower than healthy women (76.8 vs 
82, P < .001).
3.3 | Secondary outcomes
3.3.1 | PSS-10
Of the 176 women (99%) who completed the PSS-10 questionnaire 
more than half (n = 90, 51%) indicated low or average stress (<13 
points), while 23% (n = 41) experienced stress levels above average 
(between 13-20 points), and 25% (n = 45) reported high stress levels 
(>20 points). Women with TS scored significantly higher than their 
non-TS peers, indicating a higher level of perceived stress. Especially, 
women in the age group 45-59 years scored higher compared to 
their peers (n = 45:16.18 vs 12.99, P-value: .002), whereas higher 
TA B L E  2   Demographics
Demographics (N = 177) n %
Living situation 174 98
With a partner 50 29
Alone 47 27
Living with parents 44 25
Family 7 4
Friends 2 1
Children 30 16
Biological children 12 40
Foster or adopted children 11 37
After oocyte donation 7 23
Highest level of educational 
attainment
123 69
Prevocational secondary 14 11
Senior general secondary/
preuniversity
17 14
Intermediate vocational 51 41
Higher vocational 19 15
University education 13 11
Current occupation 90 51
Fulltime employed 23 26
Part-time employed 36 40
Still attend educational services 16 18
Unemployed 12 13
Sports participation 73 41
Jogging 19 26
Cycling 17 23
Fitness 16 22
Team sports 1 1
Note: Completeness per domain (eg living situation) is presented as n (%) 
of the total cohort (n = 177). Data per item is presented as n, % of the 
corresponding domain.
TA B L E  3   Associated morbidity
Morbidity (n = 177) n %
Otological problems 57 32
Cardiovascular disease 56 32
BAV 34 19
PAPVR 12 7
CoA 9 5
bovine aortic arch 2 1
Persistent duct 2 1
PLSCV 2 1
ASD 1 0.6
VSD 1 0.6
Hypothyroidism 30 17
Dento-facial malformations 26 15
Orthopaedic problems 21 12
Liver dysfunction 20 11
Renal malformations 13 7
Diabetes 6 3
Coeliac disease 3 2
Hyperthyroidism 1 1
Note: Data per item are presented as n, %.
     |  5van den HOven et al.
but nonstatically significant values where observed in the other age 
groups (18-39 years, n = 124:14.2 vs 13.34, P-value: .084) (≥60 years, 
n = 7:13.71 vs 12.82, P-value: .403).
3.3.2 | CIS-20
The CIS-20 was completed by 175 participants (99%). In our cohort, 
32% of patients (n = 56) scored 76 or higher indicating increased 
fatigue. In Figure 2, we compare our cohort of women with TS to 
reference populations from literature, showing that women with TS 
are significantly more fatigued than healthy controls, indicated by a 
higher total score (67 vs 55; P < .001). They also score significantly 
worse on the subscores of ‘fatigue’ and ‘concentration’ subscales 
compared to controls (29 vs 23; P < .001 and 17 vs 12; P < .001 re-
spectively, Figure 2).
3.3.3 | HADS
The HADS measures fear and depression in patients under medi-
cal treatment. This questionnaire was offered to 27 who showed 
F I G U R E  1   Total EQ-5D (HR-QoL) 
scores per age group in women with TS 
vs the general Dutch population. EQ-5D 
scores per decade of life. The red line 
depicts scores in women with TS. The 
blue line depicts scores in a cohort of 
healthy Dutch non- women with TS. *: 
average over all age groups (P < .003)
F I G U R E  2   Total CIS-20 (fatigue) scores in TS women vs different non-Turner syndrome reference populations from literature. Total CIS-
score per patient group colors indicates different subdomains, total CIS-20 scores are depicted on top of bars. Higher scores indicate more 
fatigue
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indications of emotional suffering on the EQ-5D and was completed 
by 20/27 eligible participants (74%). One of whom scored between 8 
and 10 points, indicating a ‘possible depression or anxiety disorder’, 
while 19 women (95%) scored above 10 points, indicative of a ‘prob-
able depression or anxiety disorder’. Since this questionnaire was 
offered only to a subset of patients, no comparison to a reference 
population could be made.
3.3.4 | Fertility and sexuality
The fertility-related quality of life (Ferti-QoL) was completed by 57 of 
the 140 eligible patients (41%). Women with TS scored significantly 
lower on the relational subscale (78 vs 71; P = .009) indicating more 
impact of fertility problems on the marriage or partnership (Figure 
S3) compared to a reference population of women who underwent 
medically assisted reproduction.29 Conversely, they scored better 
on the mind-body (90 vs 71; P < .001), social (82 vs 74; P < .001) and 
emotional subscores (81 vs 60; P < .001), indicating less impact of 
negative emotions on quality of life and impact of fertility problems, 
cognitions and behaviour on physical health. On the total Ferti-QoL 
women with TS scored higher (82 vs 71; P = .1467) indicating better 
fertility-related quality of life.
Additionally, the four questionnaires on sexual activity and sex-
ual functioning in women (sexual activity question, BSSC-W, FSFI 
and FSFD-R) were completed by 57/140 (41%), 40/140 (29%), 8/9 
(89%) and 2/5 (40%) participants, respectively. On the ‘sexual ac-
tivity question’ (mean age: 37.5 ± 8.4years), 32 women (56%) indi-
cated that they were sexually active. On the BSSC-W (mean age: 
38 ± 8.9years), 33 of the 40 respondents (82.5%) indicated that they 
were content with their sex life, 7 were not (17.5%). Causes for dis-
satisfaction with sex life included a lack of libido (n = 3; 7%), reduced 
genital sensations (n = 1; 2.4%), vaginal dryness (n = 1; 2.4%) or pain 
during intercourse (n = 2; 5%). As a part of the value-based health-
care programme, these women were then referred to a sexologist.
3.3.5 | Body image and disease burden
The BCS questionnaire on body image was answered by 175 (99%) 
women, of who 66 (37%) indicated to be discontent with their ap-
pearance. Scores of the body-image questionnaire on the 52 areas 
of physique are shown in Figure S4. Women with TS were least con-
tent with their waist, build, belly, weight and figure. Also, reflected 
in this questionnaire is the discontent with their energy level. The 
burden questionnaire was completed by 177 women (100%). Self-
reported burden scored on six domains is shown in Table S1. The 
question which asked how much these issues on the different do-
mains affected the participant on a scale from 0-10 was answered 
(n = 161; 91%) with a mean score of 4.6 (SD ± 2.6). Of the physical 
complaints, fatigue was especially frequently reported by women in 
our cohort. Other physical problems (12%) often concerned joint and 
muscle pain (4%). The most frequently reported emotional complaint 
in the ‘other emotional complaints’ category (4%) was work-related 
stress (2%). Problems in social interaction concerned the connection 
with peers (15%) or engaging in a romantic relationship (16%). In the 
‘work-related category’, issues reported often included mild neu-
ropsychological problems such as memory (19%), and concentration 
(20%) issues. The majority of other complaints in the work category 
(5%) specifically described the feeling of being overburdened by 
work (4%). Women with TS also frequently reported concerns about 
the future, often related to their education or work (30%).
3.4 | Determinants of quality of life
Univariate linear regression showed age, diabetes, liver dysfunc-
tion, orthopaedic problem, fatigue (CIS-20) and stress (PSS) to be 
associated (P < .2) with worse quality of life (EQ-5D). Subsequent 
backward multivariate linear regression analysis revealed that higher 
fatigue (β=−.004, SE < .001, P < .001), orthopaedic complaints, de-
fined as physical problems (eg scoliosis, leg length discrepancy or 
Madelung's deformity (β=−.049, SE = .027, P=.072) and diabetes 
(β=−.090, SE = .047, P = .056) were associated with worse EQ-5D 
score (r2: .508). Moreover, both PSS-10 score and CIS-20 score were 
independently associated with a lower EQ-5D outcome (β=−.014, 
P < .001 and β=−.005, P < .001, respectively). However, the PSS score 
was collinear with CIS-20 score (β=−.2454, P < .001, R2: .498) and 
since CIS-20 had the strongest correlation PSS was removed from 
the analysis. Additional piece-wise separate linear regression for the 
0.5-0.99 EQ-5D range improved the correlation, but did not change 
the outcome. Notably, the presence of cardiac disease or hearing 
impairment did not influence quality of life (EQ-5D). No significant 
difference was found between the different levels of educational at-
tainment for EQ-5D (P = .9156), CIS-20 (P = .759) or PSS-10 (P = .380) 
or for partnership status on EQ-5D (P = .488), CIS-20 (P = .055) or 
PSS-10 (P = .265). A summary of the questionnaires and their results 
has been provided in Figure S5.
4  | DISCUSSION
In order to analyse the added value of our care for patients with TS, 
we developed together with a small patients representation a set 
of clinician and patient-reported outcome variables related to items 
that really matter to them in daily life. Subsequently, we measured 
these outcome variables in a group of TS patients. This study de-
scribes the results of these measurements. In this large cohort of 
women with TS, we found an impaired health-related quality of life 
(HR-QoL), correlated to higher stress and more fatigue compared 
to control populations. When considering determinants for these 
results, we found that especially having comorbidities such as dia-
betes and orthopaedic complaints were related to lower HR-QoL. 
This impaired quality of life was reported before, in which at least 
some domains of QoL were found to be decreased in women with 
TS.26,30-36 However, three studies found QoL in women with TS to 
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be comparable to non-TS controls,37-39 or found even better scores 
by women with TS on some aspects such as social and emotional 
functioning.38 Our study further determined in which domains 
Turner patients are especially experiencing difficulties and which 
factors contributed to their reduced mental health.
Moreover, in our cohort ‘fatigue’ as measured by the CIS-20 was 
strongly correlated with a lower quality of life. Fatigue is a complaint 
frequently encountered in the care for women with TS, often in 
absence of physical disease, with no clear cause for this debilitat-
ing complaint. We also found the increased score for fatigue to be 
correlated with high stress scores, and this was not sufficiently ex-
plained by any physical comorbidities. In literature, it has been sug-
gested that women with TS exhibit greater anaerobic stress during 
exercise, leading to increased muscle fatigue.40 Also, menopausal 
symptom may affect fatigue in TS women. However, such an effect 
cannot be determined from the results in the current study.
Another remarkable finding was that almost all women with TS 
engaged in sports chose an individual sports activity (eg running or 
fitness). It might be that a team sport is too demanding for these 
women as they have impaired performance across both verbal and 
visual-spatial domains,41 or perhaps that they may feel more com-
fortable in an individual setting because of their lower satisfaction 
with their body image. This clearly warrants further study.
We also consulted a ‘Turner life coach’ involved in the value-based 
healthcare programme, for the interpretation of our results. Turner 
life coaches are women with TS who ‘coach’ Turner women in day-
to-day problems. She suggested that the extreme fatigue may par-
tially be explained by the mismatch that women with TS experience 
between what is expected of them by themselves and their envi-
ronment and what they are capable of doing. This may result from 
the impaired concentration and attention leading to impaired exec-
utive function and subsequent fatigue. This is something that is also 
clearly reflected in the work domain of the burden questionnaire. 
Another potential explanation for these findings in women with TS is 
offered by Tancredi et al, who suggest that TS patients might have an 
overactive sympathetic nervous system (SNS).42 Zuckerman et al43 
showed that TS patients have an increased resting norepinephrine 
level. These TS women also had a lower response of catecholamines 
to exercise, which may be reflected in an increased basal tone of the 
SNS, resulting in high blood pressure, relative tachycardia, shorter 
conduction times and a decreased VO2max. This may culminate in 
the increased fatigue often experienced by these women.
Stress in women with TS has been investigated by Fjermestad 
et al32 (n = 57, mean age 40.6 ± 11.1 years), showing that they expe-
rience more stress than healthy controls. We also found an increased 
stress level in our cohort of Turner patients. In addition, we found that 
stress also negatively influenced HR-QoL. However, causality cannot 
be established based on this cross-sectional study, but stress reduc-
tion might be a tool for clinicians to improve QoL in women with TS.
From literature it is well-known that fertility issues play an im-
portant role in women with TS.10,36 Indeed, the questionnaire on 
fertility was not well-responded to, showing that this issue might by 
a difficult topic for TS women. The results showed a lower relational 
quality of life but a higher score on the mind-body and emotional 
subscores compared to a retrospective cohort of Dutch women who 
underwent medically assisted reproduction. The questionnaires 
used in this study are well validated in other populations and have 
been used in clinical setting. We have not evaluated the burden of 
filling out the questionnaire itself, but it takes approximately 15 min-
utes and we feel this is a relatively small effort. We do aim to eval-
uate the acceptability in future studies. Conversely, clinicians are 
often time-pressed and the time it takes to fill in a questionnaire 
cannot be spent elsewhere. Therefore, the set-up of automated sent 
questionnaires, providing so much important information is an im-
portant asset in the assessment for the clinician. In our study, the 
feasibility was good as 177 out of the 201 women did fill in the ques-
tionnaires. An important hurdle is that some specific questionnaires 
such as the one on sexuality were only marginally filled in. This hur-
dle needs attention. Of the women that did fill in these question-
naires just over half were sexually active and of these around 80% 
were content with their sex life. There might be a selection bias of 
women feeling more comfortable completing these questionnaires 
being more positive on their sex life, compared with women who 
feel uncomfortable, it may have been confronting or women may 
have considered questions not relevant.44 Also, these question-
naires have not yet been validated specifically for the TS population 
which limits their interpretation. Therefore, future research should 
focus on developing disease-specific tools, as previous studies show 
that disease-specific HR-QoL instruments can contribute to more 
effective treatment interventions as they have more power to detect 
small differences and changes over time.15,45-47
4.1 | Clinical implications
We want to underline the need for screening with Turner specific 
questionnaires covering a broader range of HR-QoL and varying 
aspects of psychosocial functioning in women with TS. Reis et al10 
described 18 different instruments in a recent review, mostly the 
SF-36, used to assess QoL and related domains. TS, however, is a 
very heterogeneous syndrome that is not easily covered in a limited 
set of questions. However, a single validated TS specific question-
naire would in our opinion allow to more easily score QoL and act 
timely and appropriately. Considering our results, such a question-
naire would need to cover the HR-QoL aspects of the EQ-5D, stress, 
fatigue and sexuality. Indeed, if all women with TS would fill in this 
questionnaire, problems could be identified timely and possible ther-
apy can be offered and initiated. Once a common methodology has 
been established to investigate QOL in these women, other possible 
sources of bias, such as ascertainment bias due to the tendency of 
TS women to give expected responses, could be studied further. For 
some women group, sessions may provide useful support, while oth-
ers clearly need individual coaching or psychological therapy. In addi-
tion, a well-structured exercise programme may be useful in selected 
women with TS. Finally, attention for and information on sexual func-
tioning and fertility should be organized for all women with TS.
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The main limitation of our study is that not all questionnaires 
were completed by all participants, which possibly introduced bias. 
Patient who experienced higher stress, more fatigue or lower QoL 
could have been less motivated to participate in this comprehensive 
set of questionnaires. A second limitation lies in the retrospective 
manner in which electronic patient records were searched for pa-
tient-specific clinical information, which is sensitive to incomplete-
ness. All women with TS are seen in our centre and the current 
cohort should therefore be representative of the general TS pop-
ulation. Furthermore, we had no data on the women who did not 
respond to the questionnaires, we were therefore unable to assess a 
potential difference between these groups. A final limitation is that 
there was no reference data on educational attainment and part-
nership status and therefore no comparison on these aspects could 
be made. This would be an important aspect to take into account in 
designing future studies.
5  | CONCLUSION
Value-based healthcare means aiming at improving outcomes that 
really matter to patients. In order to do this, we should first measure 
these outcomes. By doing so, we showed that women with TS scored 
lower on HR-QoL and reported more stress and fatigue compared 
to healthy controls. Determinants which were found to affect HR-
QoL were physical factors, such as diabetes and orthopaedic com-
plaints, but also stress and fatigue were clearly associated with lower 
HR-QoL.
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